Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 2,025–2,032 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Immunic Inc. Vidofludimus calcium (IMU-838) - (EMPhaSIS) Relapsing-remitting multiple sclerosis (RMS) Phase 3 Data Released Oral Neurology
Immunic Inc. Vidofludimus Calcium (IMU-838) - (CALLIPER) Progressive Multiple Sclerosis Phase 2 Data Released Oral Neurology
ImmunityBio Inc. ANKTIVA (nogapendekin alfa inbakicept) - (QUILT-2.023) 1L Non Small Cell Lung Cancer (NSCLC) Phase 3 Data Released Intravesical Oncology
ImmunityBio Inc. ANKTIVA NMIBC Papillary Disease BLA Filing Ongoing Intravenous Oncology
ImmunityBio Inc. ANKTIVA NMIBC Papillary Disease BLA Filing Ongoing Intravenous Oncology
ImmunityBio Inc. Anktiva (N-803) + various Checkpoint Inhibitors (QUILT-3.055) NSCLC, Various tumors Phase 2b Data Released Intravenous Oncology
ImmunityBio Inc. ANKTIVA - (ResQ201A-NSCLC) Non-Small Cell Lung Cancer BLA Filing Trial Planned Intravenous Oncology
ImmunityBio Inc. IL-15 superagonist N-803 - (Tri-Ad5) Lynch syndrome Phase 2b Intravenous Genetic Disorder